CMRX Chimerix Inc
Chimerix Inc is a biopharmaceutical company which focuses on the discovery, development, and commercialization of novel, oral antivirals in areas of unmet medical needs.
$2.14
As of 07/01/2022 IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 04/11/2013
Outstanding shares: 87,436,180
Average volume: 4,150,442
Market cap: $181,867,254
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: B8RLM49
Valuation (See tab for details)
PE ratio: -1.86
PB ratio: 3.91
PS ratio: 325.34
Return on equity: -210.44%
Net income %: -17,994.28%